Saccharomyces boulardii to Prevent Antibiotic-Associated Diarrhea: A Randomized, Double-Masked, Placebo-Controlled Trial
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Background. Antibiotic-associated diarrhea (AAD) and Clostridium difficile-associated diarrhea (CDAD) are common complications of antibiotic use. Data on the efficacy of probiotics to prevent AAD and CDAD are unclear. We aimed to evaluate the efficacy of Saccharomyces boulardii to prevent AAD and CDAD in hospitalized adult patients. Methods. We conducted a multicenter, phase III, double-masked, randomized, placebo-controlled trial in hospitalized patients who received systemic antibiotic treatment in 15 hospitals in Germany between July 2010 and October 2012. Participants received Perenterol forte 250 mg capsules or matching placebo twice per day within 24 hours of initiating antibiotic treatment, continued treatment for 7 days after antibiotic discontinuation, and were then observed for 6 weeks. Results. Two thousand four hundred forty-four patients were screened. The trial was stopped early for futility after inclusion of 477 participants. Two hundred forty-six patients aged 60.1 ± 16.5 years and 231 patients aged 56.5 ± 17.8 were randomized to the S boulardii group and the placebo group, respectively, with 21 and 19 AADs in the respective groups (P = .87). The hazard ratio of AAD in the S boulardii group compared with the placebo group was 1.02 (95% confidence interval, .55–1.90; P = .94). Clostridium difficile-associated diarrhea occurred in 0.8% of participants (4 of 477). Nine serious adverse events were recorded in the S boulardii group, and 3 serious adverse events were recorded in the placebo group. None were related to study participation. Conclusions. We found no evidence for an effect of S boulardii in preventing AAD or CDAD in a population of hospitalized patients without particular risk factors apart from systemic antibiotic treatment. ClinicalTrials.gov Identifier. NCT01143272.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Burden of Clostridium difficile Infection in the United States
Lessa, F. C., Mu, Y., Bamberg, W. M., Beldavs, Z. G., Dumyati, G. K., Dunn, J. R., Farley, M. M., Holzbauer, S. M., Meek, J. I., Phipps, E. C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408913 · Cited by 2,641 · cited 8×
“Because of the increasing clinical importance of AAD and CDAD [12, 13] and encouraging yet inconclusive data, we tested the efficacy of Perenterol forte 250 mg capsules in addition to any antibiotic treatment for reducing the hazard of AAD in hospitalized patients in Germany.”
MethodInfluentialMcFarland, L. V. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00465.x · Cited by 872 · cited 1×
“the relative risk of AAD by approximately 60% [10, 11], the quality of the data is still weak.”
BackgroundNewberry, S. J. (2012) · JAMA · doi:10.1001/jama.2012.3507 · Cited by 870
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Goldenberg, J. Z., Ma, S. S., Saxton, J. D., Martzen, M. R., Vandvik, P. O., Thorlund, K., Guyatt, G. H., & Johnston, B. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006095.pub3 · Cited by 741
Hickson, M., D'Souza, A. L., Muthu, N., Rogers, T. R., Want, S., Rajkumar, C., & Bulpitt, C. J. (2007) · BMJ · doi:10.1136/bmj.39231.599815.55 · Cited by 599
Johnston, B. C., Ma, S. S. Y., Goldenberg, J. Z., Thorlund, K., Vandvik, P. O., Loeb, M., & Guyatt, G. H. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-12-201212180-00563 · Cited by 367
Gao, X. W., Mubasher, M., Fang, C. Y., Reifer, C., & Miller, L. E. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.11 · Cited by 318
Effect of Antibiotic Treatment on the Intestinal Metabolome
Antunes, L. C. M., Han, J., Ferreira, R. B. R., Lolić, P., Borchers, C. H., & Finlay, B. B. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01664-10 · Cited by 271
From yaks to yogurt: the history, development, and current use of probiotics
McFarland, L. V. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ054 · Cited by 248 · cited 1×
“Sales grow globally by approximately 7% per year and are predicted to be $48 billion by 2017 [6].”
BackgroundTreatment and prevention of antibiotic associated diarrhea
Bergogne-Bérézin, E. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00293-4 · Cited by 174 · cited 1×
“Consequences of AAD and CDAD include increased morbidity [4, 5] and mortality, extended hospital stays, an increased risk of developing complications such as colitis or toxic megacolon, discontinuation of the needed antibiotic, and higher healthcare cost.”
BackgroundWhelan, K., & Myers, C. E. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28759 · Cited by 161 · cited 1×
“However, some cases of generalized fungal infections occurring under unfavorable circumstances have been described [9].”
Background
Cited by
van Prehn, J., Reigadas, E., Vogelzang, E. H., Bouza, E., Hristea, A., Guery, B., Krutova, M., Norén, T., Allerberger, F., Coia, J. E., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.09.038 · Cited by 640
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Goldenberg, J. Z., Yap, C., Lytvyn, L., Lo, C. K.-F., Beardsley, J., Mertz, D., & Johnston, B. C. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006095.pub4 · Cited by 550
Antibiotics impair murine hematopoiesis by depleting the intestinal microbiota
Josefsdottir, K. S., Baldridge, M. T., Kadmon, C. S., & King, K. Y. (2017) · Blood · doi:10.1182/blood-2016-03-708594 · Cited by 343
Shen, N. T., Maw, A., Tmanova, L. L., Pino, A., Ancy, K., Crawford, C. V., Simon, M. S., & Evans, A. T. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.02.003 · Cited by 273
Goodman, C., Keating, G., Georgousopoulou, E., Hespe, C., & Levett, K. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-043054 · Cited by 163
Metadata
- Authors
- Ehrhardt, S., Guo, N., Hinz, R., Schoppen, S., May, J., Reiser, M., Schroeder, M. P., Schmiedel, S., Keuchel, M., Reisinger, E. C., Langeheinecke, A., de Weerth, A., Schuchmann, M., Schaberg, T., Ligges, S., Eveslage, M., Hagen, R. M., Burchard, G. D., Lohse, A. W., for the SacBo Study Group, Ruf, B., Porschen, R., Trenn, G., Butterfaß-Bahloul, T., Wuerthwein, G., Oeder, F., Runge, A., Klauss, E., Hansen-Rosenblatt, N., Werner, T., Schulze, K., Kreuels, B., Schäfer, G., Hübener, P., Hennigs, A., Beisel, C., Fischer-Brügge, D., Zimmermann-Fraedrich, K., Röder, C., Grigo, N., Riecke, A., Schreckenbauer, H., Hemmer, C., Klammt, S., Geerdes-Fenge, H., Frimmel, S., Kittner, J. M., Rey, J. W., Schattenberg, J. M., Thieringer, F., Schmits, R., Grandt, D., Büch, P. M., Klebert, A., Mittag, M. A., Lehnen, S., Tiefengraber, D., Radecke, K., Hering, I., Zeller, W., Rundt, L., Brandt, L., Baltes, P., Dajani, D., Kurniawan, N., Pflüger, C., Behjat, N., Engel, U., & Unger, M.
- Venue
- Open Forum Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-01-01
- Volume
- 3
- Issue
- 1
- Pages
- ofw011-ofw011
- ISSN
- 2328-8957 (ISSN-L)
- OpenAlex
- W2296893419
- Cited by
- 66
- References
- 11
- FWCI
- 11.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.